Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer.
Warapen TreekitkarnmongkolVandna ShahKazuharu KaiHiroshi KatayamaJustin W WongFarah A LadhaTristian NguyenBrian MenegazWei LuFei YangBarbara MinoXiming TangMihai GageaHarsh BatraMaria Gabriela RasoIgnacio I WistubaSavitri KrishnamurthySarah E PinderElinor J SawyerAlastair M ThompsonSubrata SenPublished in: British journal of cancer (2024)
Epigenetic activation of SOX11 drives recurrence of DCIS and progression to invasive cancer, suggesting SOX11 as a predictive biomarker of IBE.